BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 8989951)

  • 1. Intratympanic gentamicin therapy for Ménière's disease.
    Hirsch BE; Kamerer DB
    Am J Otol; 1997 Jan; 18(1):44-51. PubMed ID: 8989951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N; Martín E; García-Tapia R
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC; Minor LB
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratympanic gentamicin injection for the treatment of Meniere's disease.
    Youssef TF; Poe DS
    Am J Otol; 1998 Jul; 19(4):435-42. PubMed ID: 9661751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.
    Silverstein H; Wazen J; Van Ess MJ; Daugherty J; Alameda YA
    Otolaryngol Head Neck Surg; 2010 Apr; 142(4):570-5. PubMed ID: 20304280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
    Derebery MJ; Fisher LM; Berliner K; Chung J; Green K
    Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratympanic gentamicin titration therapy for intractable Meniere's disease.
    Atlas JT; Parnes LS
    Am J Otol; 1999 May; 20(3):357-63. PubMed ID: 10337978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
    Minor LB
    Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratympanic gentamicin treatment in Meniere's disease: patients' experiences and outcomes.
    Smith WK; Sandooram D; Prinsley PR
    J Laryngol Otol; 2006 Sep; 120(9):730-5. PubMed ID: 16848921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Auditory results after vestibular nerve section and intratympanic gentamicin for Ménière's disease.
    Colletti V; Carner M; Colletti L
    Otol Neurotol; 2007 Feb; 28(2):145-51. PubMed ID: 17255880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of intractable Menière's disease with intratympanic gentamicin: review of the University of Ottawa experience.
    Corsten M; Marsan J; Schramm D; Robichaud J
    J Otolaryngol; 1997 Dec; 26(6):361-4. PubMed ID: 9438932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hearing results following intratympanic gentamicin perfusion for Ménière's disease.
    Kyrodimos E; Aidonis I; Sismanis A
    J Laryngol Otol; 2009 Apr; 123(4):379-82. PubMed ID: 18954493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose intratympanic gentamicin instillations for treatment of Meniere's disease: long-term results.
    Hsieh LC; Lin HC; Tsai HT; Ko YC; Shu MT; Lin LH
    Acta Otolaryngol; 2009 Dec; 129(12):1420-4. PubMed ID: 19922092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease.
    Horii A; Saika T; Uno A; Nishiike S; Mitani K; Nishimura M; Kitahara T; Fukushima M; Nakagawa A; Masumura C; Sasaki T; Kizawa K; Kubo T
    Otol Neurotol; 2006 Sep; 27(6):896-900. PubMed ID: 16788414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratympanic gentamicin in Ménière's disease: results of therapy.
    Murofushi T; Halmagyi GM; Yavor RA
    Am J Otol; 1997 Jan; 18(1):52-7. PubMed ID: 8989952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Middle ear exploration in patients with Ménière's disease who have failed outpatient intratympanic gentamicin therapy.
    Crane BT; Minor LB; Della Santina CC; Carey JP
    Otol Neurotol; 2009 Aug; 30(5):619-24. PubMed ID: 19503016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term disability of class A patients with Ménière's disease after treatment with intratympanic gentamicin.
    Boleas-Aguirre MS; Sánchez-Ferrandiz N; Guillén-Grima F; Perez N
    Laryngoscope; 2007 Aug; 117(8):1474-81. PubMed ID: 17607149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratympanic gentamicin for the treatment of unilateral Meniere's disease.
    Kaplan DM; Nedzelski JM; Chen JM; Shipp DB
    Laryngoscope; 2000 Aug; 110(8):1298-305. PubMed ID: 10942130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratympanic gentamicin therapy for intractable Ménière's disease.
    De Beer L; Stokroos R; Kingma H
    Acta Otolaryngol; 2007 Jun; 127(6):605-12. PubMed ID: 17503229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distortion product otoacoustic emissions after intratympanic gentamicin therapy for unilateral Ménière's disease.
    Perez N; Boleas MS; Martin E
    Audiol Neurootol; 2005; 10(2):69-78. PubMed ID: 15650298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.